Literature DB >> 28676996

Region of interest methylation analysis: a comparison of MSP with MS-HRM and direct BSP.

Reem Akika1, Zainab Awada1, Nahed Mogharbil1, Nathalie K Zgheib2.   

Abstract

The aim of this study was to compare and contrast three DNA methylation methods of a specific region of interest (ROI): methylation-specific PCR (MSP), methylation-sensitive high resolution melting (MS-HRM) and direct bisulfite sequencing (BSP). The methylation of a CpG area in the promoter region of Estrogen receptor alpha (ESR1) was evaluated by these three methods with samples and standards of different methylation percentages. MSP data were neither reproducible nor sensitive, and the assay was not specific due to non-specific binding of primers. MS-HRM was highly reproducible and a step forward into categorizing the methylation status of the samples as percent ranges. Direct BSP was the most informative method regarding methylation percentage of each CpG site. Though not perfect, it was reproducible and sensitive. We recommend the use of either method depending on the research question and target amplicon, and provided that the designed primers and expected amplicons are within recommendations. If the research question targets a limited number of CpG sites and simple yes/no results are enough, MSP may be attempted. For short amplicons that are crowded with CpG sites and of single melting domain, MS-HRM may be the method of choice though it only indicates the overall methylation percentage of the entire amplicon. Although the assay is highly reproducible, being semi-quantitative makes it of lesser interest to study ROI methylation of samples with little methylation differences. Direct BSP is a step forward as it gives information about the methylation percentage at each CpG site.

Entities:  

Keywords:  BSP; DNA methylation; MS-HRM; MSP; ROI

Mesh:

Substances:

Year:  2017        PMID: 28676996     DOI: 10.1007/s11033-017-4110-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

1.  Methylation-sensitive high-resolution melting.

Authors:  Tomasz K Wojdacz; Alexander Dobrovic; Lise Lotte Hansen
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 2.  Optimizing methodologies for PCR-based DNA methylation analysis.

Authors:  Hernán G Hernández; M Yat Tse; Stephen C Pang; Humberto Arboleda; Diego A Forero
Journal:  Biotechniques       Date:  2013-10       Impact factor: 1.993

Review 3.  Epigenetics in atherosclerosis: a clinical perspective.

Authors:  Bi-Kui Zhang; Xin Lai; Su-Jie Jia
Journal:  Discov Med       Date:  2015-02       Impact factor: 2.970

Review 4.  DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers.

Authors:  Shinichi Fukushige; Akira Horii
Journal:  Tohoku J Exp Med       Date:  2013-03       Impact factor: 1.848

5.  Rapid quantification of DNA methylation by measuring relative peak heights in direct bisulfite-PCR sequencing traces.

Authors:  Minghong Jiang; Yuhao Zhang; Jing Fei; Xinxia Chang; Weiwei Fan; Xueqing Qian; Tianbao Zhang; Daru Lu
Journal:  Lab Invest       Date:  2009-12-14       Impact factor: 5.662

6.  A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis.

Authors:  Kirsten Hattermann; H Maximilian Mehdorn; Rolf Mentlein; Susann Schultka; Janka Held-Feindt
Journal:  Anal Biochem       Date:  2008-03-14       Impact factor: 3.365

7.  Mapping of ER gene CpG island methylation-specific polymerase chain reaction.

Authors:  R G Lapidus; S J Nass; K A Butash; F F Parl; S A Weitzman; J G Graff; J G Herman; N E Davidson
Journal:  Cancer Res       Date:  1998-06-15       Impact factor: 12.701

Review 8.  Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis.

Authors:  Afroza Khanam Irin; Alpha Tom Kodamullil; Michaela Gündel; Martin Hofmann-Apitius
Journal:  J Immunol Res       Date:  2015-11-09       Impact factor: 4.818

9.  Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR.

Authors:  Aiala Lorente; Wolf Mueller; Edurne Urdangarín; Paula Lázcoz; Andreas von Deimling; Javier S Castresana
Journal:  BMC Cancer       Date:  2008-02-25       Impact factor: 4.430

10.  Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene.

Authors:  Ida L M Candiloro; Thomas Mikeska; Peter Hokland; Alexander Dobrovic
Journal:  Epigenetics Chromatin       Date:  2008-11-03       Impact factor: 4.954

View more
  4 in total

1.  Development and performance evaluation of TaqMan real-time fluorescence quantitative methylation specific PCR for detecting methylation level of PER2.

Authors:  Huihui Jiang; Xin Yang; Miaomiao Mi; Xiaonan Wei; Hongyuan Wu; Yu Xin; Liping Jiao; Shengjun Sun; Chengming Sun
Journal:  Mol Biol Rep       Date:  2021-12-01       Impact factor: 2.316

2.  Novel multiplex stool-based assay for the detection of early-stage colon cancer in a Chinese population.

Authors:  Hui-Hong Jiang; Si-Wei Xing; Xuan Tang; Ying Chen; Kang Lin; Lu-Wei He; Mou-Bin Lin; Er-Jiang Tang
Journal:  World J Gastroenterol       Date:  2022-06-28       Impact factor: 5.374

3.  Influence of pre-pregnancy body mass index (p-BMI) and gestational weight gain (GWG) on DNA methylation and protein expression of obesogenic genes in umbilical vein.

Authors:  Erika Chavira-Suárez; Angélica Jazmín Ramírez-Mendieta; Sofía Martínez-Gutiérrez; Paola Zárate-Segura; Jorge Beltrán-Montoya; Nidia Carolina Espinosa-Maldonado; Juan Carlos de la Cerda-Ángeles; Felipe Vadillo-Ortega
Journal:  PLoS One       Date:  2019-12-03       Impact factor: 3.240

4.  DNA methylation analysis with methylation-sensitive high-resolution melting (MS-HRM) reveals gene panel for glioma characteristics.

Authors:  Aleksandra Majchrzak-Celińska; Emilia Dybska; Anna-Maria Barciszewska
Journal:  CNS Neurosci Ther       Date:  2020-08-11       Impact factor: 5.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.